GlassScriptPhysician profile
Robert G Sawyer
NPI 1699806836
$30,704.49
in general payments reported to CMS, 2019-2025
9 companies · $6,937 in 2025
The $6,937 reported for 2025 was more than what 92% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,275 · 2020: $2,745 · 2021: $2,435 · 2022: $659 · 2023: $8,787 · 2024: $6,866 · 2025: $6,937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $1,964 · Food and Beverage: $1,142 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,464.50 |
| Travel and Lodging | $1,963.62 |
| Food and Beverage | $1,141.87 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $17,431.96 | 2023-2025 | Biogel Indicator System, Biogel Pi Indicator Underglove, Biogel Pi Micro |
| Tetraphase Pharmaceuticals, INC. | $6,902.30 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $2,500.00 | 2020 | |
| Cardinal Health 200 LLC | $2,200.00 | 2021 | |
| Shionogi INC | $1,405.50 | 2020-2024 | Fetroja |
| Gilead Sciences, INC. | $96.55 | 2023 | |
| Abbvie INC. | $71.20 | 2022 | |
| Haemonetics Corporation | $63.54 | 2023 | Teg6s Hemostasis System |
| Csl Behring | $33.44 | 2024 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.